Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript

Christopher O'Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited.

Related Keywords

United States ,Colombia ,Japan ,Indonesia ,Brazil ,Ireland ,Argentina ,Thailand ,Irish ,America ,Japanese ,Christophe Weber ,Christopher Oreilly ,Hidemaru Yamaguchi ,Citi Yamaguchi San ,Ramona Sequeira ,Seiji Wakao ,Shinichiro Muraoka ,Julie Kim ,Takeda Pharmaceutical Company ,Takeda Pharmaceutical Co Ltd ,Morgan Stanley ,Unidentified Company Representative ,American College Of Rheumatology ,Global Portfolio Division ,Takeda Pharmaceutical Company Limited ,World Health Organization Advisory Group ,Call Transcript October ,Second Quarter Fiscal ,Private Securities Litigation Reform Act ,Andy Plump ,Chief Financial Officer ,Costa Saroukos ,American College ,World Health Organization ,Advisory Group ,Amyotrophic Lateral Sclerosis ,Furuta Milano ,Japan Pharma Business ,Popular Sparkling Wine Brands ,With Huge Catalysts ,Muraoka San This ,Company Representative ,Im Wakao ,